LBO — GEISINGER MEDICAL CENTER
IRR: 24.2% | MOIC: 2.96x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
24.2%
IRR
2.96x
MOIC
$673.6M
Entry EV
$1.3B
Exit EV
$346.6M
Equity Invested
Sources & Uses
S&UTotal · $673.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $261.6M | 38.8% | |
| Sub Debt | $65.4M | 9.7% | |
| Equity | $346.6M | 51.5% | |
| Enterprise Value | $654.0M | 97.1% | |
| Transaction Fees | $19.6M | 2.9% | |
| Total Uses | $673.6M | 100.0% |
Interpretation
INTAt 2.96x MOIC and 24.2% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $127.7M |
| Exit Ev | $1.3B |
| Net Debt At Exit | $316.2M |
| Equity At Exit | $1.0B |
| Equity Invested | $346.6M |
| Total Value Created | $678.1M |
| Value From Growth | $654.2M |
| Value From Multiple | $32.7M |
| Value From Deleveraging | $10.8M |